Women's Fem Dophilus By Jarrow Formulas Overview & Drug Interactions

Check For Interactions With Women's Fem Dophilus

Supplement: Women's Fem Dophilus by Jarrow Formulas

Women's Fem Dophilus Label Images

supplement image

View and download

full size label image

This product contains

Below is a list of the 'active' ingredients listed on the supplement label for this product.

For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.

Drugs that interact with Women's Fem Dophilus by Jarrow Formulas

Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.

There were no interactions found with Women's Fem Dophilus. This does not mean the potential for an interaction does not exist, however. There is often a lack of studies and data surrounding traditional medicine, especially concerning drug interactions, so it is important to always consult your provider before making any changes to your medication regimen.

Still looking for more information about Women's Fem Dophilus interactions? Ask Dr. Brian Staiger about it by contacting him directly.

Label Information

Supplement Facts:

Daily Value (DV) Target Group(s): Adults and children 4 or more years of age
Minimum serving Sizes:
1 Capsule(s)
Maximum serving Sizes:
1 Capsule(s)
Servings per container 30
UPC/BARCODE 790011030058

Ingredient Amount per Serving Group % DV, Adults & children 4+ years
Total Probiotic Blend
5000000000 Viable Cell(s)
Blend (non-nutrient/non-botanical) --
Lactobacillus rhamnosus, GR-1
0 NP
Lactobacillus rhamnosus
Lactobacillus reuteri, RC-14
0 NP
Lactobacillus reuteri

Other Ingredients:
Anhydrous Dextrose
Potato Starch
Cellulose
Magnesium Stearate
Capsule
Forms
  • Gelatin
  • Titanium Dioxide


Label Statments:


Suggested/Recommended/Usage/Directions
- Suggested Use: For maintenance, take 1 capsule orally per day and increase to 2 capsules per day as needed or take as directed by your qualified healthcare professional.
- 5 Billion viable cells per capsule when kept refrigerated and within Best Used Before Date.
Storage
- Keep refrigerated.
Precautions
- Keep out of reach of children.
- Contains: Dairy (casein, in trace amounts).
General Statements
- Under license from Chr. Hansen A/S and protected by Chr. Hansen A/S patents of the WO 00/35465 patent family, and others.
- VAGINAL/URINARY TRACT HEALTH
- Made in Denmark by Chr. Hansen A/S
- 02514FEM60 PROD # 103035
- 25+ YEARS OF RESEARCH/CLINICAL STUDIES
FDA Disclaimer Statement
- *These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
Seals/Symbols
- GLUTEN FREE
FDA Statement of Identity
- ORAL PROBIOTIC SUPPLEMENT
Formula
- Contains: Dairy (casein, in trace amounts).
- Fem-Dophilus(R) contains two patented and clinically documented probiotic strains, Lactobacillus rhamnosus, GR-1(R) and Lactobacillus reuteri, RC-14(R), discovered and developed by Dr. Gregor Reid and Dr. Andrew Bruce at Urex Biotech.
- PATENTED STRAINS LACTOBACILLUS RHAMNOSUS GR-1(R) and LACTOBACILLUS REUTERI RC-14(R)
Formulation
- No wheat, no gluten, no soybeans, no egg, no fish/shellfish, no peanuts/tree nuts.
Brand IP Statement(s)
- GR-1(R)/RC-14(R) and VAGINAL FLORA In one of the randomized clinical trials, 75% of women in the GR-1(R)/RC-14(R) probiotic + antibiotic group experienced significant improvement in vaginal flora composition, while only 34% of women in the placebo (antibiotic only) group experienced similar improvement. GR-1/RC-14(R) 75% Control Group 34%
- Martinez, et al. Improved cure of bacterial vaginosis with single dose of tinidazole (2 g), Lactobacillus rhamnosus GR-1(R), and Lactobacillus reuteri RC-14(R) : a randomized, double-blind, placebo-controlled trial. Can J Microbiol 2009;55:133-138 {chart} 25+ YEARS OF GR-1(R)/ RC-14(R) RESEARCH / CLINICAL STUDIES Fem-Dophilus(R) Introduced (2006) 1988 1994 2000 2006 2012 2014 1988-First Research on GR-1(R)/RC-14(R) Strains Begin -27 Clinical Studies Published Between 2001 and 2014
- Over 25 years of research supports the oral use of GR-1(R) and RC-14(R) to colonize and promote healthy vaginal and urinary tract health.* A special manufacturing process protects the probiotic strains in Fem-Dophilus(R) from stomach acid and enhances probiotic bacterial survival to the lower intestine.
- Jarrow Formulas(R) puts the “PRO” in probiotics(R)
- (C) 2014 Jarrow FORMULAS(R)
- RC-14(R) and GR-1(R) are Trademarks of Chr. Hansen A/S.
General
- 04214FEM PROD # 103005

Brand Information

See all products by this brand

Distributed Exclusively by
Name Jarrow Formulas Superior Nutrition and Formulation
Street Address P.O. Box 35994
City Los Angeles
State CA
ZipCode 90035-4317
Web Address www.Jarrow.com

Return to the main supplement interaction checker page

Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Drug descriptions are provided by MedlinePlus.